Patient,Sample,Sample_Type,Drug_Name,Drug_CID,Response,TCGA_Code,Prediction
TCGA-AC-A62V,TCGA-AC-A62V-01A-11R-A31O-07,Primary Tumor,Paclitaxel,36314,Partial Response,BRCA,-2.50241
TCGA-OL-A5S0,TCGA-OL-A5S0-01A-11R-A28M-07,Primary Tumor,TAXOL,36314,Complete Response,BRCA,-3.5472717
TCGA-CE-A481,TCGA-CE-A481-01A-21R-A23W-07,Primary Tumor,Doxorubicin,31703,Complete Response,THCA,-2.7432814
TCGA-CE-A482,TCGA-CE-A482-01A-11R-A23W-07,Primary Tumor,Doxorubicin,31703,Complete Response,THCA,-1.0264142
TCGA-A5-A1OH,TCGA-A5-A1OH-01A-21R-A22K-07,Primary Tumor,Carboplatin,426756,Complete Response,UCEC,3.754946
TCGA-A5-A3LP,TCGA-A5-A3LP-01A-11R-A22K-07,Primary Tumor,Carboplatin,426756,Complete Response,UCEC,4.554489
TCGA-BG-A2L7,TCGA-BG-A2L7-01A-11R-A18M-07,Primary Tumor,Carboplatin,426756,Complete Response,UCEC,3.125379
TCGA-DI-A2QY,TCGA-DI-A2QY-01A-12R-A19W-07,Primary Tumor,Paclitaxel,36314,Complete Response,UCEC,-3.7764869
TCGA-DI-A2QY,TCGA-DI-A2QY-11A-11R-A19W-07,Solid Tissue Normal,Paclitaxel,36314,Complete Response,UCEC,-3.6871629
TCGA-QF-A5YT,TCGA-QF-A5YT-01A-11R-A31O-07,Primary Tumor,Cisplatin,5702198,Complete Response,UCEC,2.9267755
TCGA-AA-3662,TCGA-AA-3662-11A-01R-1723-07,Solid Tissue Normal,Capecitabine,60953,Partial Response,COAD,2.426559
TCGA-AA-3662,TCGA-AA-3662-01A-01R-1723-07,Primary Tumor,Capecitabine,60953,Partial Response,COAD,2.8706346
TCGA-AA-3713,TCGA-AA-3713-11A-01R-1723-07,Solid Tissue Normal,5-Fluorouracil,3385,Partial Response,COAD,4.2250395
TCGA-AA-3713,TCGA-AA-3713-01A-21R-1723-07,Primary Tumor,5-Fluorouracil,3385,Partial Response,COAD,2.6580849
TCGA-AA-3930,TCGA-AA-3930-01A-01R-1022-07,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,COAD,1.9382505
TCGA-AA-3994,TCGA-AA-3994-01A-01R-1113-07,Primary Tumor,Capecitabine,60953,Complete Response,COAD,2.4697344
TCGA-AA-A00J,TCGA-AA-A00J-01A-02R-A002-07,Primary Tumor,5-Fluorouracil,3385,Partial Response,COAD,3.6997643
TCGA-AD-6889,TCGA-AD-6889-01A-11R-1928-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,1.4569212
TCGA-AD-6901,TCGA-AD-6901-01A-11R-1928-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,2.2826498
TCGA-AZ-4616,TCGA-AZ-4616-01A-21R-1839-07,Primary Tumor,XELODA,60953,Stable Disease,COAD,1.8075644
TCGA-AZ-6606,TCGA-AZ-6606-01A-11R-1839-07,Primary Tumor,5 FU,3385,Clinical Progressive Disease,COAD,3.0620708
TCGA-F4-6805,TCGA-F4-6805-01A-11R-1839-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,1.7703128
TCGA-F4-6807,TCGA-F4-6807-01A-11R-1839-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.92531955
TCGA-QG-A5YV,TCGA-QG-A5YV-01A-11R-A28H-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,2.0011425
TCGA-QG-A5YX,TCGA-QG-A5YX-01A-11R-A28H-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,2.7787285
TCGA-2W-A8YY,TCGA-2W-A8YY-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9484171
TCGA-C5-A1BQ,TCGA-C5-A1BQ-01C-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.7345214
TCGA-DS-A5RQ,TCGA-DS-A5RQ-01A-11R-A28H-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.2377462
TCGA-DS-A7WF,TCGA-DS-A7WF-01A-11R-A352-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,2.8546453
TCGA-DS-A7WH,TCGA-DS-A7WH-01A-22R-A352-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5062048
TCGA-DS-A7WI,TCGA-DS-A7WI-01A-12R-A352-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.4784987
TCGA-EA-A3QD,TCGA-EA-A3QD-01A-32R-A22U-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.5146226
TCGA-EK-A2H0,TCGA-EK-A2H0-01A-11R-A180-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.2154846
TCGA-EK-A2RL,TCGA-EK-A2RL-01A-11R-A18M-07,Primary Tumor,Taxol,36314,Clinical Progressive Disease,CESC,-2.883112
TCGA-EX-A3L1,TCGA-EX-A3L1-01A-11R-A32Y-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.006647
TCGA-FU-A23L,TCGA-FU-A23L-01A-11R-A16R-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.391864
TCGA-FU-A3HY,TCGA-FU-A3HY-01A-11R-A21T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.4028108
TCGA-FU-A3HZ,TCGA-FU-A3HZ-01A-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.6766517
TCGA-HM-A4S6,TCGA-HM-A4S6-01A-11R-A26T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5962205
TCGA-IR-A3L7,TCGA-IR-A3L7-01A-21R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.3047452
TCGA-IR-A3LC,TCGA-IR-A3LC-01A-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.5090895
TCGA-IR-A3LH,TCGA-IR-A3LH-01A-21R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7144358
TCGA-IR-A3LL,TCGA-IR-A3LL-01A-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.5657345
TCGA-MA-AA3W,TCGA-MA-AA3W-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9314859
TCGA-MA-AA3X,TCGA-MA-AA3X-01A-22R-A42S-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.5317092
TCGA-MY-A5BD,TCGA-MY-A5BD-01A-11R-A26T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.625733
TCGA-MY-A5BF,TCGA-MY-A5BF-11A-11R-A26T-07,Solid Tissue Normal,Cisplatin,5702198,Complete Response,CESC,3.1757295
TCGA-MY-A5BF,TCGA-MY-A5BF-01A-11R-A26T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.8551285
TCGA-MY-A913,TCGA-MY-A913-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.1795623
TCGA-Q1-A5R2,TCGA-Q1-A5R2-01A-11R-A28H-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,2.847882
TCGA-Q1-A5R3,TCGA-Q1-A5R3-01A-11R-A28H-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,3.7579367
TCGA-Q1-A73O,TCGA-Q1-A73O-01A-11R-A32P-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9257483
TCGA-UC-A7PG,TCGA-UC-A7PG-01A-11R-A42S-07,Primary Tumor,cisplatin,5702198,Clinical Progressive Disease,CESC,3.4297616
TCGA-UC-A7PG,TCGA-UC-A7PG-06A-11R-A42S-07,Metastatic,cisplatin,5702198,Clinical Progressive Disease,CESC,2.3298042
TCGA-VS-A8EH,TCGA-VS-A8EH-01A-11R-A36F-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.4253762
TCGA-VS-A8EI,TCGA-VS-A8EI-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.01119
TCGA-VS-A8EK,TCGA-VS-A8EK-01A-12R-A37O-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,3.6953263
TCGA-VS-A8EL,TCGA-VS-A8EL-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.2275944
TCGA-VS-A8QC,TCGA-VS-A8QC-01A-11R-A37O-07,Primary Tumor,Paclitaxel,36314,Clinical Progressive Disease,CESC,-3.4505959
TCGA-VS-A8QF,TCGA-VS-A8QF-01A-21R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.5975482
TCGA-VS-A94W,TCGA-VS-A94W-01A-12R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.0419948
TCGA-VS-A94X,TCGA-VS-A94X-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,2.526618
TCGA-VS-A94Y,TCGA-VS-A94Y-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,2.3238752
TCGA-VS-A94Z,TCGA-VS-A94Z-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.0374694
TCGA-VS-A954,TCGA-VS-A954-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.4245825
TCGA-VS-A957,TCGA-VS-A957-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.190308
TCGA-VS-A958,TCGA-VS-A958-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.7108803
TCGA-VS-A9U5,TCGA-VS-A9U5-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.406661
TCGA-VS-A9U6,TCGA-VS-A9U6-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Stable Disease,CESC,2.078548
TCGA-VS-A9U7,TCGA-VS-A9U7-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5547304
TCGA-VS-A9UB,TCGA-VS-A9UB-01A-22R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.8140523
TCGA-VS-A9UC,TCGA-VS-A9UC-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Stable Disease,CESC,4.097272
TCGA-VS-A9UD,TCGA-VS-A9UD-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.6602201
TCGA-VS-A9UH,TCGA-VS-A9UH-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.2451866
TCGA-VS-A9UO,TCGA-VS-A9UO-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5946684
TCGA-VS-A9UP,TCGA-VS-A9UP-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9372392
TCGA-VS-A9UR,TCGA-VS-A9UR-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.4752119
TCGA-VS-A9UU,TCGA-VS-A9UU-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.909025
TCGA-VS-A9UY,TCGA-VS-A9UY-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,1.8047901
TCGA-VS-A9V0,TCGA-VS-A9V0-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.7941742
TCGA-VS-A9V1,TCGA-VS-A9V1-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,3.03122
TCGA-VS-A9V3,TCGA-VS-A9V3-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9489491
TCGA-VS-A9V5,TCGA-VS-A9V5-01A-11R-A42T-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,CESC,3.806731
TCGA-VS-AA62,TCGA-VS-AA62-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,1.3159784
TCGA-CF-A47S,TCGA-CF-A47S-01A-11R-A23W-07,Primary Tumor,Doxobubicin,31703,Complete Response,BLCA,-0.82859397
TCGA-DK-A6B2,TCGA-DK-A6B2-01A-11R-A30C-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,BLCA,0.18603218
TCGA-DK-AA6W,TCGA-DK-AA6W-01A-12R-A39I-07,Primary Tumor,Gemcitabine,60750,Stable Disease,BLCA,-3.3938298
TCGA-GV-A3QI,TCGA-GV-A3QI-01A-11R-A220-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,BLCA,-1.9769125
TCGA-4G-AAZO,TCGA-4G-AAZO-01A-12R-A41I-07,Primary Tumor,GEMCITABINE,60750,Stable Disease,CHOL,-1.0297031
TCGA-W5-AA2H,TCGA-W5-AA2H-01A-31R-A41I-07,Primary Tumor,gemcitabine,60750,Complete Response,CHOL,-4.10464
TCGA-W5-AA2T,TCGA-W5-AA2T-01A-12R-A41I-07,Primary Tumor,Gemcitabine,60750,Complete Response,CHOL,-2.168153
TCGA-ZH-A8Y4,TCGA-ZH-A8Y4-01A-11R-A41I-07,Primary Tumor,Gemzar,60750,Partial Response,CHOL,-1.7241752
TCGA-JY-A93D,TCGA-JY-A93D-01A-11R-A38D-31,Primary Tumor,Fluorouracil,3385,Complete Response,ESCA,4.4981194
TCGA-LN-A49M,TCGA-LN-A49M-01A-21R-A260-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,1.9105221
TCGA-LN-A49O,TCGA-LN-A49O-01A-11R-A24K-31,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,ESCA,1.1695001
TCGA-LN-A49Y,TCGA-LN-A49Y-01A-11R-A260-31,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,ESCA,1.6065524
TCGA-LN-A4A6,TCGA-LN-A4A6-01A-11R-A260-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,1.6206685
TCGA-LN-A5U6,TCGA-LN-A5U6-01A-11R-A28J-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,1.5749114
TCGA-LN-A7HV,TCGA-LN-A7HV-01A-21R-A354-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,1.679011
TCGA-LN-A7HX,TCGA-LN-A7HX-01A-11R-A336-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,1.5655435
TCGA-LN-A9FP,TCGA-LN-A9FP-01A-31R-A38D-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,3.6217964
TCGA-LN-A9FR,TCGA-LN-A9FR-01A-11R-A38D-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,2.1531818
TCGA-VR-A8EQ,TCGA-VR-A8EQ-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,ESCA,4.040846
TCGA-PK-A5HB,TCGA-PK-A5HB-01A-11R-A29S-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,ACC,3.005709
TCGA-KN-8428,TCGA-KN-8428-11A-01R-2315-07,Solid Tissue Normal,sorafenib,216239,Clinical Progressive Disease,KICH,3.1630063
TCGA-KN-8428,TCGA-KN-8428-01A-11R-2315-07,Primary Tumor,sorafenib,216239,Clinical Progressive Disease,KICH,2.5121584
TCGA-BA-A4IF,TCGA-BA-A4IF-01A-11R-A266-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.2154706
TCGA-BA-A4IH,TCGA-BA-A4IH-01A-11R-A266-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,1.4650086
TCGA-BA-A6D8,TCGA-BA-A6D8-01A-31R-A31N-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.5691237
TCGA-BA-A6DA,TCGA-BA-A6DA-01A-31R-A31N-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.948527
TCGA-BA-A6DD,TCGA-BA-A6DD-01A-12R-A31N-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,HNSC,3.0605183
TCGA-BA-A6DI,TCGA-BA-A6DI-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.3438578
TCGA-BA-A6DJ,TCGA-BA-A6DJ-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.6202638
TCGA-BB-7864,TCGA-BB-7864-01A-11R-2232-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.314225
TCGA-BB-7866,TCGA-BB-7866-01A-11R-2232-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.0391085
TCGA-BB-7872,TCGA-BB-7872-01A-11R-2232-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.6332495
TCGA-BB-A5HU,TCGA-BB-A5HU-01A-11R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.0195045
TCGA-BB-A5HY,TCGA-BB-A5HY-01A-11R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.8329337
TCGA-CN-6998,TCGA-CN-6998-01A-23R-2016-07,Primary Tumor,cisplatin,5702198,Clinical Progressive Disease,HNSC,3.1104426
TCGA-CN-A49A,TCGA-CN-A49A-01A-11R-A24H-07,Primary Tumor,carboplatin,426756,Complete Response,HNSC,4.4299536
TCGA-CN-A63T,TCGA-CN-A63T-01A-11R-A28V-07,Primary Tumor,CISPLATIN,5702198,Complete Response,HNSC,3.209546
TCGA-CN-A641,TCGA-CN-A641-01A-11R-A30B-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,3.7507007
TCGA-CN-A6UY,TCGA-CN-A6UY-01A-12R-A34R-07,Primary Tumor,carboplatin,426756,Complete Response,HNSC,3.4841194
TCGA-CN-A6V3,TCGA-CN-A6V3-01A-12R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.6059322
TCGA-CN-A6V6,TCGA-CN-A6V6-01A-12R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.361981
TCGA-CN-A6V7,TCGA-CN-A6V7-01A-12R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.4786086
TCGA-CQ-A4CH,TCGA-CQ-A4CH-01A-11R-A266-07,Primary Tumor,cisplatin,5702198,Partial Response,HNSC,3.1472268
TCGA-D6-A6EK,TCGA-D6-A6EK-01A-11R-A31N-07,Primary Tumor,cisplatin,5702198,Partial Response,HNSC,3.176316
TCGA-DQ-7595,TCGA-DQ-7595-01A-11R-2232-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.7978873
TCGA-F7-A50J,TCGA-F7-A50J-01A-21R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.2694514
TCGA-HD-8314,TCGA-HD-8314-01A-11R-2403-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.0600104
TCGA-IQ-A61E,TCGA-IQ-A61E-01A-22R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.084566
TCGA-IQ-A61G,TCGA-IQ-A61G-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,HNSC,2.6070673
TCGA-IQ-A61J,TCGA-IQ-A61J-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.8156223
TCGA-IQ-A61O,TCGA-IQ-A61O-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.793933
TCGA-KU-A6H7,TCGA-KU-A6H7-01A-11R-A31N-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,1.9625539
TCGA-KU-A6H7,TCGA-KU-A6H7-06A-21R-A31N-07,Metastatic,Cisplatin,5702198,Complete Response,HNSC,2.9012535
TCGA-MZ-A5BI,TCGA-MZ-A5BI-01A-31R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.592955
TCGA-P3-A5Q6,TCGA-P3-A5Q6-01A-11R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.6493576
TCGA-P3-A6SW,TCGA-P3-A6SW-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.8994274
TCGA-P3-A6T2,TCGA-P3-A6T2-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.7674203
TCGA-P3-A6T3,TCGA-P3-A6T3-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.0251658
TCGA-P3-A6T6,TCGA-P3-A6T6-01A-11R-A34R-07,Primary Tumor,Taxol,36314,Clinical Progressive Disease,HNSC,-2.8006797
TCGA-P3-A6T7,TCGA-P3-A6T7-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.9778457
TCGA-P3-A6T8,TCGA-P3-A6T8-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,4.057211
TCGA-T2-A6X0,TCGA-T2-A6X0-01A-11R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,3.3626626
TCGA-TN-A7HJ,TCGA-TN-A7HJ-01A-12R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.397952
TCGA-TN-A7HL,TCGA-TN-A7HL-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,1.9833549
TCGA-UF-A7JC,TCGA-UF-A7JC-01A-21R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.0652673
TCGA-UF-A7JF,TCGA-UF-A7JF-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.249714
TCGA-UF-A7JJ,TCGA-UF-A7JJ-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.6336536
TCGA-UF-A7JK,TCGA-UF-A7JK-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.201849
TCGA-UF-A7JT,TCGA-UF-A7JT-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.6653535
TCGA-2Y-A9GV,TCGA-2Y-A9GV-01A-11R-A38B-07,Primary Tumor,Naxavar,216239,Clinical Progressive Disease,LIHC,2.5767317
TCGA-BC-A8YO,TCGA-BC-A8YO-01A-11R-A37K-07,Primary Tumor,Nexavar,216239,Partial Response,LIHC,2.56903
TCGA-BW-A5NP,TCGA-BW-A5NP-01A-11R-A27V-07,Primary Tumor,Nexavar,216239,Clinical Progressive Disease,LIHC,2.9529824
TCGA-CC-A8HV,TCGA-CC-A8HV-01A-11R-A36F-07,Primary Tumor,Nexavar,216239,Clinical Progressive Disease,LIHC,2.9370484
TCGA-DD-A1EJ,TCGA-DD-A1EJ-01A-11R-A155-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.5621362
TCGA-DD-A1EJ,TCGA-DD-A1EJ-11A-11R-A155-07,Solid Tissue Normal,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.8062387
TCGA-DD-A1EK,TCGA-DD-A1EK-01A-11R-A213-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.9142847
TCGA-DD-A3A4,TCGA-DD-A3A4-11A-11R-A22L-07,Solid Tissue Normal,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-1.9811244
TCGA-DD-A3A4,TCGA-DD-A3A4-01A-11R-A22L-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-1.7283943
TCGA-DD-A4NH,TCGA-DD-A4NH-01A-11R-A27V-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,3.0487134
TCGA-FV-A3I0,TCGA-FV-A3I0-11A-11R-A22L-07,Solid Tissue Normal,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-0.580276
TCGA-FV-A3I0,TCGA-FV-A3I0-01A-11R-A22L-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-0.3669784
TCGA-G3-A3CG,TCGA-G3-A3CG-01A-11R-A213-07,Primary Tumor,Sorafenib,216239,Stable Disease,LIHC,2.7515888
TCGA-G3-A3CJ,TCGA-G3-A3CJ-01A-11R-A213-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.7055798
TCGA-G3-A5SI,TCGA-G3-A5SI-01A-31R-A27V-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.5939686
TCGA-WX-AA44,TCGA-WX-AA44-01A-11R-A39D-07,Primary Tumor,SORAFENIB,216239,Partial Response,LIHC,2.419362
TCGA-WX-AA47,TCGA-WX-AA47-01A-11R-A39D-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.999619
TCGA-LK-A4NZ,TCGA-LK-A4NZ-01A-12R-A34F-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,MESO,3.2928255
TCGA-LK-A4O0,TCGA-LK-A4O0-01A-11R-A34F-07,Primary Tumor,Cisplatinum,5702198,Complete Response,MESO,2.4396372
TCGA-19-5960,TCGA-19-5960-01A-11R-1850-01,Primary Tumor,Temodar,5394,Stable Disease,GBM,6.1638765
TCGA-DB-A4XB,TCGA-DB-A4XB-01A-11R-A26U-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.1115093
TCGA-DB-A4XD,TCGA-DB-A4XD-01A-11R-A27Q-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.2411633
TCGA-DB-A4XF,TCGA-DB-A4XF-01A-11R-A27Q-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.2930517
TCGA-DB-A4XG,TCGA-DB-A4XG-01A-11R-A27Q-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.1743617
TCGA-DB-A64O,TCGA-DB-A64O-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.215211
TCGA-DB-A64P,TCGA-DB-A64P-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.391559
TCGA-DB-A64V,TCGA-DB-A64V-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.267209
TCGA-DB-A64W,TCGA-DB-A64W-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.089216
TCGA-DB-A64X,TCGA-DB-A64X-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.254038
TCGA-DB-A75K,TCGA-DB-A75K-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.3780336
TCGA-DH-A66B,TCGA-DH-A66B-01A-11R-A29R-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,5.983515
TCGA-DH-A66D,TCGA-DH-A66D-01A-11R-A31N-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.381384
TCGA-DH-A66G,TCGA-DH-A66G-01A-21R-A31N-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.5888295
TCGA-DH-A7UR,TCGA-DH-A7UR-01A-11R-A33Z-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.0950184
TCGA-DH-A7UT,TCGA-DH-A7UT-01A-12R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.317985
TCGA-DH-A7UU,TCGA-DH-A7UU-01A-12R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.4446783
TCGA-DH-A7UV,TCGA-DH-A7UV-01A-12R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.4032397
TCGA-DU-8162,TCGA-DU-8162-01A-21R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.363925
TCGA-DU-8163,TCGA-DU-8163-01A-11R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.367356
TCGA-DU-8165,TCGA-DU-8165-01A-11R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.418859
TCGA-DU-8168,TCGA-DU-8168-01A-11R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.234871
TCGA-DU-A5TP,TCGA-DU-A5TP-01A-11R-A28M-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.223295
TCGA-DU-A5TS,TCGA-DU-A5TS-01A-11R-A28M-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.618969
TCGA-DU-A5TU,TCGA-DU-A5TU-01A-11R-A28M-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.20331
TCGA-DU-A6S6,TCGA-DU-A6S6-01A-21R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.1961493
TCGA-DU-A6S7,TCGA-DU-A6S7-01A-21R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.287269
TCGA-DU-A76K,TCGA-DU-A76K-01A-11R-A33Z-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.202963
TCGA-DU-A76O,TCGA-DU-A76O-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.108648
TCGA-DU-A76R,TCGA-DU-A76R-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.42527
TCGA-DU-A7TA,TCGA-DU-A7TA-01A-11R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.070855
TCGA-E1-A7YK,TCGA-E1-A7YK-01A-11R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.2479377
TCGA-E1-A7YS,TCGA-E1-A7YS-01A-11R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.335015
TCGA-FG-6689,TCGA-FG-6689-01A-11R-1896-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.399389
TCGA-FG-7638,TCGA-FG-7638-01B-12R-2090-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.300698
TCGA-FG-8181,TCGA-FG-8181-01A-11R-2256-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.395544
TCGA-FG-8189,TCGA-FG-8189-01B-11R-A28M-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.238561
TCGA-FG-8191,TCGA-FG-8191-01A-11R-2256-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.7598424
TCGA-FG-A4MW,TCGA-FG-A4MW-01A-11R-A26U-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.488677
TCGA-FG-A6J3,TCGA-FG-A6J3-01A-11R-A31N-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.153214
TCGA-FG-A70Y,TCGA-FG-A70Y-01A-12R-A34R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.5122137
TCGA-FG-A710,TCGA-FG-A710-01A-12R-A33Z-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.452995
TCGA-FN-7833,TCGA-FN-7833-01A-11R-2090-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.1663985
TCGA-HT-7477,TCGA-HT-7477-01B-11R-A28M-07,Primary Tumor,Temodar,5394,Complete Response,LGG,5.967168
TCGA-HT-7483,TCGA-HT-7483-01A-11R-2027-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.1632967
TCGA-HT-7604,TCGA-HT-7604-01A-11R-2090-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.1185803
TCGA-HT-7884,TCGA-HT-7884-01B-11R-2403-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.2132936
TCGA-HT-8013,TCGA-HT-8013-01A-11R-2403-07,Primary Tumor,Temodar,5394,Clinical Progressive Disease,LGG,6.0446033
TCGA-HT-8114,TCGA-HT-8114-01A-11R-2404-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.4476457
TCGA-HT-A5RA,TCGA-HT-A5RA-01A-11R-A28M-07,Primary Tumor,Temodar,5394,Partial Response,LGG,5.971276
TCGA-HT-A5RC,TCGA-HT-A5RC-01A-11R-A28M-07,Primary Tumor,Temodar,5394,Clinical Progressive Disease,LGG,5.9782324
TCGA-HT-A619,TCGA-HT-A619-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.117897
TCGA-HT-A61C,TCGA-HT-A61C-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.254904
TCGA-HT-A74K,TCGA-HT-A74K-01A-11R-A32Q-07,Primary Tumor,temodar,5394,Complete Response,LGG,6.1596894
TCGA-HW-8320,TCGA-HW-8320-01A-11R-2404-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.276558
TCGA-HW-8321,TCGA-HW-8321-01A-11R-2404-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3918986
TCGA-HW-A5KK,TCGA-HW-A5KK-01A-11R-A27Q-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.5016055
TCGA-HW-A5KL,TCGA-HW-A5KL-01A-11R-A27Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.2749176
TCGA-IK-8125,TCGA-IK-8125-01A-11R-2256-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.443899
TCGA-KT-A74X,TCGA-KT-A74X-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3138285
TCGA-KT-A7W1,TCGA-KT-A7W1-01A-11R-A34F-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,5.885922
TCGA-P5-A5EX,TCGA-P5-A5EX-01A-12R-A28M-07,Primary Tumor,Temozolomide,5394,Partial Response,LGG,6.264307
TCGA-QH-A65R,TCGA-QH-A65R-01A-21R-A31N-07,Primary Tumor,TEMOZOLOMIDE,5394,Stable Disease,LGG,6.2929482
TCGA-QH-A6CY,TCGA-QH-A6CY-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3076944
TCGA-QH-A6X4,TCGA-QH-A6X4-01A-51R-A32Q-07,Primary Tumor,temozolomide,5394,Clinical Progressive Disease,LGG,6.414786
TCGA-QH-A6X8,TCGA-QH-A6X8-01A-12R-A32Q-07,Primary Tumor,temozolomide,5394,Stable Disease,LGG,6.53022
TCGA-S9-A6TV,TCGA-S9-A6TV-01A-12R-A34R-07,Primary Tumor,Temozolamide,5394,Stable Disease,LGG,6.0645356
TCGA-S9-A6TW,TCGA-S9-A6TW-01A-12R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.5916557
TCGA-S9-A6TX,TCGA-S9-A6TX-01A-21R-A32Q-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.4657664
TCGA-S9-A6TY,TCGA-S9-A6TY-01A-12R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.273275
TCGA-S9-A6U1,TCGA-S9-A6U1-01A-21R-A33Z-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,5.917164
TCGA-S9-A6WD,TCGA-S9-A6WD-01A-12R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3097963
TCGA-S9-A6WG,TCGA-S9-A6WG-01A-11R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.634791
TCGA-S9-A6WM,TCGA-S9-A6WM-01A-12R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,5.956368
TCGA-S9-A7QW,TCGA-S9-A7QW-01A-11R-A34F-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.1414285
TCGA-S9-A7QY,TCGA-S9-A7QY-01A-11R-A34F-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.259284
TCGA-S9-A7R1,TCGA-S9-A7R1-01A-12R-A34R-07,Primary Tumor,Temozolamide,5394,Stable Disease,LGG,6.561411
TCGA-S9-A7R4,TCGA-S9-A7R4-01A-12R-A34R-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.5735116
TCGA-S9-A89V,TCGA-S9-A89V-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.431388
TCGA-S9-A89Z,TCGA-S9-A89Z-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.345049
TCGA-TM-A84B,TCGA-TM-A84B-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.2265477
TCGA-TM-A84C,TCGA-TM-A84C-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.311352
TCGA-TM-A84L,TCGA-TM-A84L-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.2809267
TCGA-VM-A8C8,TCGA-VM-A8C8-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3462534
TCGA-VM-A8CF,TCGA-VM-A8CF-01A-11R-A36H-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.0840936
TCGA-VV-A829,TCGA-VV-A829-01A-21R-A36H-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.425173
TCGA-VW-A7QS,TCGA-VW-A7QS-01A-12R-A33Z-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.3338
TCGA-WH-A86K,TCGA-WH-A86K-01A-11R-A36H-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3833547
TCGA-3B-A9HT,TCGA-3B-A9HT-01A-11R-A39D-07,Primary Tumor,CISPLATINUM,5702198,Complete Response,SARC,2.1035104
TCGA-DX-A6B8,TCGA-DX-A6B8-01A-11R-A30C-07,Primary Tumor,Adriamycin,31703,Clinical Progressive Disease,SARC,-1.3082516
TCGA-FX-A3RE,TCGA-FX-A3RE-01A-11R-A22K-07,Primary Tumor,Adriamycin,31703,Complete Response,SARC,-2.2468014
TCGA-IF-A3RQ,TCGA-IF-A3RQ-01A-11R-A22K-07,Primary Tumor,Adriamycin,31703,Partial Response,SARC,-1.2753489
TCGA-IF-A4AJ,TCGA-IF-A4AJ-01A-11R-A24X-07,Primary Tumor,Adriamycin,31703,Clinical Progressive Disease,SARC,-2.4601798
TCGA-IS-A3K7,TCGA-IS-A3K7-01A-11R-A21T-07,Primary Tumor,Doxorubicin,31703,Partial Response,SARC,-1.3497734
TCGA-K1-A6RU,TCGA-K1-A6RU-01A-11R-A32Q-07,Primary Tumor,Adriamycin,31703,Clinical Progressive Disease,SARC,-1.3500707
TCGA-LI-A67I,TCGA-LI-A67I-01A-31R-A30C-07,Primary Tumor,Doxil,31703,Clinical Progressive Disease,SARC,-1.8108642
TCGA-MO-A47P,TCGA-MO-A47P-01A-11R-A24X-07,Primary Tumor,Doxorubicin,31703,Complete Response,SARC,-1.4031413
TCGA-X6-A7WC,TCGA-X6-A7WC-01A-12R-A355-07,Primary Tumor,Gemcitabine,60750,Stable Disease,SARC,-2.7239103
TCGA-AF-A56N,TCGA-AF-A56N-01A-12R-A39D-07,Primary Tumor,xeloda,60953,Complete Response,READ,2.328801
TCGA-AG-3593,TCGA-AG-3593-01A-01R-0821-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.5000296
TCGA-AG-3600,TCGA-AG-3600-01A-01R-0826-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.9691541
TCGA-AG-3894,TCGA-AG-3894-01A-01R-1119-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.1684468
TCGA-AG-4022,TCGA-AG-4022-01A-01R-1736-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.4817877
TCGA-AG-A00H,TCGA-AG-A00H-01A-01R-A00A-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,4.86229
TCGA-AG-A01L,TCGA-AG-A01L-01A-01R-A002-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.6405563
TCGA-AG-A01W,TCGA-AG-A01W-01A-21R-A083-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.9392624
TCGA-AG-A01Y,TCGA-AG-A01Y-01A-41R-A083-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.9832575
TCGA-AG-A036,TCGA-AG-A036-01A-12R-A083-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.06922
TCGA-DY-A1DC,TCGA-DY-A1DC-01A-31R-A155-07,Primary Tumor,Capecitabine -xeloda,60953,Partial Response,READ,1.7067969
TCGA-2L-AAQA,TCGA-2L-AAQA-01A-21R-A38C-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.0228705
TCGA-2L-AAQE,TCGA-2L-AAQE-01A-11R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.2396204
TCGA-2L-AAQI,TCGA-2L-AAQI-01A-12R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-0.07390106
TCGA-2L-AAQJ,TCGA-2L-AAQJ-01A-12R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.470892
TCGA-3A-A9IZ,TCGA-3A-A9IZ-01A-12R-A41B-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.0802412
TCGA-F2-6879,TCGA-F2-6879-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Partial Response,PAAD,-1.91165
TCGA-F2-6880,TCGA-F2-6880-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-0.708375
TCGA-F2-7276,TCGA-F2-7276-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.6207724
TCGA-F2-A8YN,TCGA-F2-A8YN-01A-11R-A37L-07,Primary Tumor,Gemzar,60750,Clinical Progressive Disease,PAAD,-1.095952
TCGA-FB-A78T,TCGA-FB-A78T-01A-12R-A32O-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-2.1523733
TCGA-FB-AAPY,TCGA-FB-AAPY-01A-11R-A41B-07,Primary Tumor,Gemzar,60750,Complete Response,PAAD,-2.3349147
TCGA-FB-AAQ6,TCGA-FB-AAQ6-01A-11R-A41B-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-0.7354336
TCGA-HV-AA8X,TCGA-HV-AA8X-01A-11R-A39D-07,Primary Tumor,Gemcitabine Injection,60750,Clinical Progressive Disease,PAAD,-0.54837036
TCGA-HZ-7920,TCGA-HZ-7920-01A-11R-2204-07,Primary Tumor,5-FU,3385,Complete Response,PAAD,4.4457426
TCGA-HZ-7923,TCGA-HZ-7923-01A-12R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-3.0461664
TCGA-HZ-7924,TCGA-HZ-7924-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-2.1975508
TCGA-HZ-8317,TCGA-HZ-8317-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-0.33367634
TCGA-HZ-8637,TCGA-HZ-8637-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-4.3268514
TCGA-HZ-A49G,TCGA-HZ-A49G-01A-11R-A26U-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.9987817
TCGA-HZ-A49H,TCGA-HZ-A49H-01A-11R-A26U-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-3.0790586
TCGA-HZ-A49I,TCGA-HZ-A49I-01A-12R-A26U-07,Primary Tumor,5-FU,3385,Clinical Progressive Disease,PAAD,5.2680516
TCGA-HZ-A77O,TCGA-HZ-A77O-01A-11R-A33R-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.2708685
TCGA-HZ-A77P,TCGA-HZ-A77P-01A-11R-A33R-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-0.9840305
TCGA-IB-7644,TCGA-IB-7644-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.354354
TCGA-IB-7647,TCGA-IB-7647-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-3.4883528
TCGA-IB-7652,TCGA-IB-7652-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-0.92942
TCGA-IB-7885,TCGA-IB-7885-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-2.719771
TCGA-IB-7889,TCGA-IB-7889-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.7203197
TCGA-IB-8126,TCGA-IB-8126-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.2028878
TCGA-IB-8127,TCGA-IB-8127-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-2.0690594
TCGA-IB-A5SO,TCGA-IB-A5SO-01A-11R-A32O-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.1388946
TCGA-IB-A5SP,TCGA-IB-A5SP-01A-11R-A32O-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.4010353
TCGA-IB-A5SS,TCGA-IB-A5SS-01A-11R-A32O-07,Primary Tumor,Gemcitabine,60750,Partial Response,PAAD,-0.43095207
TCGA-IB-AAUO,TCGA-IB-AAUO-01A-12R-A38C-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.758699
TCGA-L1-A7W4,TCGA-L1-A7W4-01A-12R-A36G-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.6950848
TCGA-Q3-A5QY,TCGA-Q3-A5QY-01A-12R-A32O-07,Primary Tumor,Gemcitabine,60750,Partial Response,PAAD,-4.4067926
TCGA-RB-AA9M,TCGA-RB-AA9M-01A-11R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-0.36335874
TCGA-S4-A8RM,TCGA-S4-A8RM-01A-11R-A37L-07,Primary Tumor,Gemzar,60750,Complete Response,PAAD,-1.9383461
TCGA-US-A774,TCGA-US-A774-01A-21R-A32O-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.5963979
TCGA-YB-A89D,TCGA-YB-A89D-11A-11R-A36G-07,Solid Tissue Normal,Gemcitabine,60750,Complete Response,PAAD,-2.1422424
TCGA-YB-A89D,TCGA-YB-A89D-01A-12R-A36G-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.2920384
TCGA-49-AAR2,TCGA-49-AAR2-01A-11R-A39D-07,Primary Tumor,TAXOL,36314,Complete Response,LUAD,-2.0036747
TCGA-50-5068,TCGA-50-5068-01A-01R-1628-07,Primary Tumor,Taxol,36314,Clinical Progressive Disease,LUAD,-2.6555996
TCGA-50-5936,TCGA-50-5936-01A-11R-1628-07,Primary Tumor,TAXOL,36314,Clinical Progressive Disease,LUAD,-2.1395097
TCGA-50-5936,TCGA-50-5936-11A-01R-1628-07,Solid Tissue Normal,TAXOL,36314,Clinical Progressive Disease,LUAD,-2.1039476
TCGA-50-6595,TCGA-50-6595-01A-12R-1858-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,LUAD,3.5443983
TCGA-50-6595,TCGA-50-6595-11A-01R-1858-07,Solid Tissue Normal,Carboplatin,426756,Clinical Progressive Disease,LUAD,4.164755
TCGA-55-7910,TCGA-55-7910-01A-11R-2170-07,Primary Tumor,Cisplatin,5702198,Complete Response,LUAD,3.681684
TCGA-93-A4JP,TCGA-93-A4JP-01A-11R-A24X-07,Primary Tumor,Carboplatin,426756,Partial Response,LUAD,3.7810283
TCGA-2A-A8VT,TCGA-2A-A8VT-01A-11R-A37L-07,Primary Tumor,Lupron,657181,Stable Disease,PRAD,1.503454
TCGA-CH-5741,TCGA-CH-5741-01A-11R-1580-07,Primary Tumor,Leuprorelin,657181,Complete Response,PRAD,1.4616439
TCGA-HC-7742,TCGA-HC-7742-11A-01R-2118-07,Solid Tissue Normal,Eligard,657181,Partial Response,PRAD,2.0663605
TCGA-HC-7742,TCGA-HC-7742-01A-11R-2118-07,Primary Tumor,Eligard,657181,Partial Response,PRAD,1.631667
TCGA-HC-A9TE,TCGA-HC-A9TE-01A-11R-A41O-07,Primary Tumor,Eligard,657181,Stable Disease,PRAD,1.7986782
TCGA-HI-7168,TCGA-HI-7168-01A-11R-2118-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,2.6492207
TCGA-KC-A4BR,TCGA-KC-A4BR-01A-32R-A32Y-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.8378592
TCGA-KK-A59Y,TCGA-KK-A59Y-01A-11R-A26U-07,Primary Tumor,Leuprolide Acetate,657181,Complete Response,PRAD,1.3844973
TCGA-KK-A6E1,TCGA-KK-A6E1-01A-11R-A311-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.7305188
TCGA-KK-A8I4,TCGA-KK-A8I4-01A-11R-A36G-07,Primary Tumor,Lupron,657181,Stable Disease,PRAD,1.2414311
TCGA-KK-A8I7,TCGA-KK-A8I7-01A-21R-A36G-07,Primary Tumor,Leuprolide Acetate,657181,Complete Response,PRAD,1.5530264
TCGA-KK-A8I9,TCGA-KK-A8I9-01A-11R-A36G-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,2.0295277
TCGA-KK-A8ID,TCGA-KK-A8ID-01A-11R-A36G-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.8072095
TCGA-YL-A9WL,TCGA-YL-A9WL-01A-11R-A41O-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.53806
TCGA-37-A5EL,TCGA-37-A5EL-01A-11R-A26W-07,Primary Tumor,Temodal,5394,Partial Response,LUSC,6.0724163
TCGA-43-5668,TCGA-43-5668-01A-01R-1635-07,Primary Tumor,Gemzar,60750,Clinical Progressive Disease,LUSC,-3.4639258
TCGA-85-8664,TCGA-85-8664-01A-11R-2403-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,LUSC,3.8344216
TCGA-90-A59Q,TCGA-90-A59Q-01A-11R-A26W-07,Primary Tumor,Cisplatin,5702198,Complete Response,LUSC,2.1435885
TCGA-2G-AAF1,TCGA-2G-AAF1-01A-11R-A430-07,Primary Tumor,Carboplatin,426756,Complete Response,TGCT,3.4124017
TCGA-WZ-A7V4,TCGA-WZ-A7V4-01A-11R-A431-07,Primary Tumor,Carboplatin,426756,Complete Response,TGCT,3.5580292
TCGA-YU-A90Q,TCGA-YU-A90Q-01A-11R-A431-07,Primary Tumor,Carboplatin,426756,Complete Response,TGCT,3.8489301
TCGA-XM-AAZ1,TCGA-XM-AAZ1-01A-11R-A42C-07,Primary Tumor,Cisplatin,5702198,Stable Disease,THYM,1.8076782
TCGA-D3-A1Q3,TCGA-D3-A1Q3-06A-11R-A18T-07,Metastatic,Cisplatin,5702198,Complete Response,SKCM,2.6615114
TCGA-EB-A3XC,TCGA-EB-A3XC-01A-11R-A239-07,Primary Tumor,Dacarbazine,135398738,Complete Response,SKCM,5.522791
TCGA-EB-A3Y6,TCGA-EB-A3Y6-01A-21R-A239-07,Primary Tumor,Dacarbazine,135398738,Complete Response,SKCM,5.5625024
TCGA-EE-A185,TCGA-EE-A185-06A-11R-A18S-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.792846
TCGA-EE-A29Q,TCGA-EE-A29Q-06A-11R-A18T-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.7261887
TCGA-EE-A29V,TCGA-EE-A29V-06A-12R-A18S-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.793052
TCGA-EE-A2MD,TCGA-EE-A2MD-06A-11R-A18T-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.248713
TCGA-EE-A2MN,TCGA-EE-A2MN-06A-11R-A18S-07,Metastatic,Dacabarzine,135398738,Clinical Progressive Disease,SKCM,5.1383457
TCGA-EE-A2MQ,TCGA-EE-A2MQ-06A-11R-A18S-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.43245
TCGA-EE-A3JI,TCGA-EE-A3JI-06A-11R-A21D-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.4964237
TCGA-FR-A8YC,TCGA-FR-A8YC-06A-11R-A37K-07,Metastatic,2B3-101,31703,Clinical Progressive Disease,SKCM,-2.0258691
TCGA-HR-A2OH,TCGA-HR-A2OH-06A-11R-A18U-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.3351994
TCGA-N6-A4VC,TCGA-N6-A4VC-01A-11R-A28V-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,UCS,3.5954497
TCGA-NA-A4QW,TCGA-NA-A4QW-01A-11R-A28V-07,Primary Tumor,Taxol,36314,Complete Response,UCS,-3.44693
TCGA-ND-A4WC,TCGA-ND-A4WC-01A-21R-A28V-07,Primary Tumor,Carboplatin,426756,Complete Response,UCS,3.3850143
TCGA-B7-A5TK,TCGA-B7-A5TK-01A-12R-A36D-31,Primary Tumor,Xeloda,60953,Complete Response,STAD,3.3179836
TCGA-B7-A5TN,TCGA-B7-A5TN-01A-21R-A31P-31,Primary Tumor,Cisplatin,5702198,Complete Response,STAD,2.9331245
TCGA-BR-A4J8,TCGA-BR-A4J8-01A-11R-A251-31,Primary Tumor,Xeloda,60953,Complete Response,STAD,3.0732687
TCGA-CD-8533,TCGA-CD-8533-01A-11R-2343-13,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,STAD,1.6638458
TCGA-CD-A48A,TCGA-CD-A48A-01A-12R-A36D-31,Primary Tumor,Capecitabine,60953,Complete Response,STAD,2.7623756
TCGA-CG-4444,TCGA-CG-4444-01A-01R-1157-13,Primary Tumor,5-Fluorouracil,3385,Complete Response,STAD,4.0369306
TCGA-CG-5724,TCGA-CG-5724-01A-11R-1602-13,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,STAD,4.206604
TCGA-D7-8579,TCGA-D7-8579-01A-11R-2343-13,Primary Tumor,5-fluorouracilum,3385,Complete Response,STAD,5.0804415
TCGA-F1-A72C,TCGA-F1-A72C-01A-21R-A33Y-31,Primary Tumor,Capecitabine,60953,Complete Response,STAD,3.4873705
TCGA-FP-7829,TCGA-FP-7829-01A-11R-2055-13,Primary Tumor,5-FU,3385,Complete Response,STAD,4.3047595
TCGA-FP-7829,TCGA-FP-7829-11A-01R-2055-13,Solid Tissue Normal,5-FU,3385,Complete Response,STAD,5.888627
TCGA-FP-7916,TCGA-FP-7916-01A-11R-2203-13,Primary Tumor,Xeloda,60953,Clinical Progressive Disease,STAD,2.9539366
TCGA-FP-A4BE,TCGA-FP-A4BE-01A-12R-A24K-31,Primary Tumor,5-FU,3385,Complete Response,STAD,2.66289
TCGA-HU-8243,TCGA-HU-8243-01A-11R-2343-13,Primary Tumor,5-FU,3385,Complete Response,STAD,5.5976734
TCGA-HU-8249,TCGA-HU-8249-01A-11R-A36D-31,Primary Tumor,Xeloda,60953,Complete Response,STAD,2.4426768
TCGA-HU-8602,TCGA-HU-8602-01A-11R-2402-13,Primary Tumor,Xeloda,60953,Complete Response,STAD,1.7682965
TCGA-KB-A6F7,TCGA-KB-A6F7-01A-12R-A32D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.170568
TCGA-KB-A93J,TCGA-KB-A93J-01A-11R-A39E-31,Primary Tumor,5-fluorouracil,3385,Complete Response,STAD,4.801852
TCGA-VQ-A8DT,TCGA-VQ-A8DT-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.8188615
TCGA-VQ-A8DU,TCGA-VQ-A8DU-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.9089704
TCGA-VQ-A8DZ,TCGA-VQ-A8DZ-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.0673447
TCGA-VQ-A8E0,TCGA-VQ-A8E0-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.829853
TCGA-VQ-A8E2,TCGA-VQ-A8E2-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.357254
TCGA-VQ-A8P3,TCGA-VQ-A8P3-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.5825973
TCGA-VQ-A8PB,TCGA-VQ-A8PB-01A-11R-A39E-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.9136481
TCGA-VQ-A8PD,TCGA-VQ-A8PD-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.1123567
TCGA-VQ-A8PP,TCGA-VQ-A8PP-01A-21R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.7314396
TCGA-VQ-A8PU,TCGA-VQ-A8PU-01A-12R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.8760824
TCGA-VQ-A91D,TCGA-VQ-A91D-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.3269453
TCGA-VQ-A91E,TCGA-VQ-A91E-01A-31R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.8868184
TCGA-VQ-A91K,TCGA-VQ-A91K-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.8434992
TCGA-VQ-A91N,TCGA-VQ-A91N-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.4787655
TCGA-VQ-A91Q,TCGA-VQ-A91Q-01A-12R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,5.083397
TCGA-VQ-A91S,TCGA-VQ-A91S-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.844562
TCGA-VQ-A91W,TCGA-VQ-A91W-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,2.8112416
TCGA-VQ-A91Y,TCGA-VQ-A91Y-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.1606293
TCGA-VQ-A922,TCGA-VQ-A922-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.715003
TCGA-VQ-A928,TCGA-VQ-A928-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.3976383
TCGA-VQ-A94O,TCGA-VQ-A94O-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.1656957
TCGA-VQ-A94R,TCGA-VQ-A94R-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.3348813
TCGA-VQ-AA64,TCGA-VQ-AA64-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.7376213
TCGA-VQ-AA68,TCGA-VQ-AA68-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.2833395
TCGA-VQ-AA6B,TCGA-VQ-AA6B-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.948565
TCGA-VQ-AA6D,TCGA-VQ-AA6D-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.4388123
TCGA-VQ-AA6F,TCGA-VQ-AA6F-01A-31R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.2861104
TCGA-VQ-AA6G,TCGA-VQ-AA6G-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.200513
TCGA-VQ-AA6K,TCGA-VQ-AA6K-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.37148
